Targeting TLR3 with no RIG-I/MDA5 activation is effective in immunotherapy for cancer

Bibliography

• Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001;413:732-8
   PubMed Web of Science ®Google Scholar
• Poltorak A, He X, Smirnova I, Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998;282:2085-8
   PubMed Web of Science ®Google Scholar
• Oshiumi H, Matsumoto M, Funami K, TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat Immunol 2003;4:161-7
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Kikkawa S, Kohase M, Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem Biophys Res Commun 2002;293:1364-9
   PubMed Web of Science ®Google Scholar
• Yoneyama M, Kikuchi M, Natsukawa T, The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004;5:730-7
   PubMed Web of Science ®Google Scholar
• Yoneyama M, Kikuchi M, Matsumoto K, Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 2005;175:2851-8
   PubMed Web of Science ®Google Scholar
• Kato H, Takeuchi O, Sato S, Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006;441:101-5
   PubMed Web of Science ®Google Scholar
• Gitlin L, Barchet W, Gilfillan S, Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci USA 2006;103:8459-64
   PubMed Web of Science ®Google Scholar
• Ermolaeva MA, Michallet MC, Papadopoulou N, Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses. Nat Immunol 2008;9:1037-46
   PubMed Web of Science ®Google Scholar
• Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 2010;11:700-14
   PubMed Web of Science ®Google Scholar
• Shime H, Matsumoto M, Oshiumi H, Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors. Proc Natl Acad Sci USA 2012;109:2066-71
   PubMed Web of Science ®Google Scholar
• Oshiumi H, Tsujita T, Shida K, Prediction of the prototype of the human Toll-like receptor gene family from the pufferfish, Fugu rubripes, genome. Immunogenetics 2003;54:791-800
   PubMed Web of Science ®Google Scholar
• Matsuo A, Oshiumi H, Tsujita T, Teleost TLR22 recognizes RNA duplex to induce IFN and protect cells from birnaviruses. J Immunol 2008;181:3474-85
   PubMed Web of Science ®Google Scholar
• Seya T, Matsumoto M, Ebihara T, Oshiumi H. Functional evolution of the TICAM-1 pathway for extrinsic RNA sensing. Immunol Rev 2009;227:44-53
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Funami K, Tanabe M, Subcellular localization of toll-like receptor 3 in human dendritic cells. J Immunol 2003;171:3154-62
   PubMed Web of Science ®Google Scholar
• Johnsen IB, Nguyen TT, Ringdal M, Toll-like receptor 3 associates with c-Src tyrosine kinase on endosomes to initiate antiviral signaling. EMBO J 2006;25:3335-46
   PubMed Web of Science ®Google Scholar
• Schulz O, Diebold SS, Chen M, Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 2005;433:887-92
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Seya T. TLR3: interferon induction by double-stranded RNA including poly(I:C). Adv Drug Deliv Rev 2008;60:805-12
   PubMed Web of Science ®Google Scholar
• Jongbloed SL, Kassianos AJ, McDonald KJ, Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J Exp Med 2010;207:1247-60
   PubMed Web of Science ®Google Scholar
• Salaun B, Coste I, Rissoan MC, TLR3 can directly trigger apoptosis in human cancer cells. J Immunol 2006;176:4894-901
   PubMed Web of Science ®Google Scholar
• Nakamura M, Funami K, Komori A, Increased expression of Toll-like receptor 3 in ntrahepatic biliary epithelial cells at sites of ductular reaction in diseasedlivers. Hepatol Int 2008;2:222-30
   PubMed Web of Science ®Google Scholar
• Choe J, Kelker MS, Wilson IA. Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science 2005;309:581-5
   PubMed Web of Science ®Google Scholar
• Liu L, Botos I, Wang Y, Structural basis of toll-like receptor 3 signaling with double-stranded RNA. Science 2008;320:379-81
   PubMed Web of Science ®Google Scholar
• Jelinek I, Leonard JN, Price GE, TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection. J Immunol 2011;186:2422-9
   PubMed Web of Science ®Google Scholar
• Akira S. Toll-like receptor signaling. J Biol Chem 2003;278:38105-8
   PubMed Web of Science ®Google Scholar
• Funami K, Sasai M, Ohba Y, Spatiotemporal mobilization of Toll/IL-1 receptor domain-containing adaptor molecule-1 in response to dsRNA. J Immunol 2007;179:6867-72
   PubMed Web of Science ®Google Scholar
• Funami K, Sasai M, Oshiumi H, Homo-oligomerization is essential for Toll/interleukin-1 receptor domain-containing adaptor molecule-1-mediated NF-kappaB and interferon regulatory factor-3 activation. J Biol Chem 2008;283:18283-91
   PubMed Web of Science ®Google Scholar
• Salaun B, Coste I, Rissoan MC, TLR3 can directly trigger apoptosis in human cancer cells. J Immunol 2006;176:4894-901
   PubMed Web of Science ®Google Scholar
• McComb S, Cheung HH, Korneluk RG, cIAP1 and cIAP2 limit macrophage necroptosis by inhibiting Rip1 and Rip3 activation. Cell Death Differ 2012;19(11):1791-801
   PubMed Web of Science ®Google Scholar
• Conforti R, Ma Y, Morel Y, Opposing effects of toll-like receptor (TLR3) signaling in tumors can be therapeutically uncoupled to optimize the anticancer efficacy of TLR3 ligands. Cancer Res 2010;70:490-500
   PubMed Web of Science ®Google Scholar
• Salaun B, Zitvogel L, Asselin-Paturel C, TLR3 as a biomarker for the therapeutic efficacy of double-stranded RNA in breast cancer. Cancer Res 2011;71:1607-14
   Google Scholar
• Akazawa T, Ebihara T, Okuno M, Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells. Proc Natl Acad Sci USA 2007;104:252-7
   PubMedGoogle Scholar
• Lucas M, Schachterle W, Oberle K, Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 2007;26:503-17
   PubMed Web of Science ®Google Scholar
• Azuma M, Ebihara T, Oshiumi H, Cross-priming for antitumor CTL induced by soluble Ag + polyI:C depends on the TICAM-1 pathway in mouse CD11c(+)/CD8alpha(+) dendritic cells. Oncoimmunology 2012;1:581-92
   PubMed Web of Science ®Google Scholar
• Baron S, Bogomolova NN, Billiau A, Induction of interferon by preparations of synthetic single-stranded RNA. Proc Natl Acad Sci USA 1969;64:67-74
   PubMed Web of Science ®Google Scholar
• Available from: http://www.innate-pharma.com/sites/default/files/uploads/IPH_3102_Nonconfidential_Summary_Feb10.pdf
   Google Scholar
• Bernard JJ, Cowing-Zitron C, Nakatsuji T, Ultraviolet radiation damages self noncoding RNA and is detected by TLR3. Nat Med 2012;18:1286-90
   PubMed Web of Science ®Google Scholar
• Tatematsu M, Nishikawa F, Seya T, Matsumoto M. TLR3 recognizes single-stranded RNA with incomplete stem structures. Nat Commun 2013; submitted
   PubMed Web of Science ®Google Scholar
• Navabi H, Jasani B, Reece A, A clinical grade poly I:C-analogue (Ampligen) promotes optimal DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro. Vaccine 2009;27:107-15
   PubMed Web of Science ®Google Scholar
• Levy HB, Baer G, Baron S, A modified polyriboinosinicpolyribocytidylic acid complex that induces interferon in primates. J Infect Dis 1975;132:434-9
   PubMed Web of Science ®Google Scholar
• Stephen EL, Hilmas DE, Mangiafico JA, Levy HB. Swine influenza virus vaccine: potentiation of antibody responses in rhesus monkeys. Science 1977;197:1289-90
   PubMed Web of Science ®Google Scholar
• Levy HB, Lvovsky E. Topical treatment of vaccinia virus infection with an interferon inducer in rabbits. J Infect Dis 1978;137:78-81
   Google Scholar
• Olsen GA, Kern ER, Overall JC Jr. Effect of treatment with exogenous interferon, polyriboinosinic-polyribocytidylic acid, or polyriboinosinic-polyribocytidylic acid poly-L-lysine complex on Herpesvirus hominis infections in mice. J Infect Dis 1978;137:428-36
   PubMed Web of Science ®Google Scholar
• Machida H, Takezawa J, Kuninaka A, Interferon induction and therapy of brain tumors in rats by poly(ICLC). Microbiol Immunol 1982;26:353-8
   Google Scholar
• Galluzzi L, Vacchelli E, Eggemont A, Trial watch: experimental toll-like receptor agonists for cancer therapy. Oncoimmunology 2012;1:699-716
   PubMed Web of Science ®Google Scholar
• Braun W, Nakano M. Antibody formation: stimulation by polyadenylic and polycytidylic acids. Science 1967;157:819-21
   PubMed Web of Science ®Google Scholar
• Sugiyama T, Hoshino K, Saito M, Immunoadjuvant effects of polyadenylic:polyuridylic acids through TLR3 and TLR7. Int Immunol 2008;20:1-9
   PubMed Web of Science ®Google Scholar
• Perrot I, Deauvieau F, Massacrier C, TLR3 and Rig-like receptor on myeloid dendritic cells and Rig-like receptor on human NK cells are both mandatory for production of IFN-gamma in response to double-stranded RNA. J Immunol 2010;185:2080-8
   PubMed Web of Science ®Google Scholar
• Bot A, Smith D, Phillips B, Immunologic control of tumors by in vivo Fc gamma receptor-targeted antigen loading in conjunction with double-stranded RNA-mediated immune modulation. J Immunol 2006;176:1363-74
   PubMed Web of Science ®Google Scholar
• Huang B, Zhao J, Li H, Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res 2005;65:5009-14
   PubMed Web of Science ®Google Scholar
• Morikawa T, Sugiyama A, Kume H, Identification of Toll-like receptor 3 as a potential therapeutic target in clear cell renal cell carcinoma. Clin Cancer Res 2007;13:5703-9
   PubMed Web of Science ®Google Scholar
• Kleinman ME, Yamada K, Takeda A, Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 2008;452:591-7
   PubMed Web of Science ®Google Scholar
• Yu L, Chen S. Toll-like receptors expressed in tumor cells: targets for therapy. Cancer Immunol Immunother 2008;57:1271-8
   PubMed Web of Science ®Google Scholar
• Baron S, Bogomolova NN, Billiau A, Induction of interferon by preparations of synthetic single-stranded RNA. Proc Natl Acad Sci USA 1969;64:67-74
   PubMed Web of Science ®Google Scholar
• Seya T, Matsumoto M. The extrinsic RNA-sensing pathway for adjuvant immunotherapy of cancer. Cancer Immunol Immunother 2009;58:1175-84
   PubMedGoogle Scholar
• Yu M, Levine SJ. Toll-like receptor, RIG-I-like receptors and the NLRP3 inflammasome: key modulators of innate immune responses to double-stranded RNA viruses. Cytokine Growth Factor Rev 2011;22:63-72
   PubMed Web of Science ®Google Scholar
• Ebihara T, Azuma M, Oshiumi H, Identification of a polyI:C-inducible membrane protein that participates in dendritic cell-mediated natural killer cell activation. J Exp Med 2010;207:2675-87
   PubMedGoogle Scholar
• Kumar H, Koyama S, Ishii KJ, Cutting edge: cooperation of IPS-1- and TRIF-dependent pathways in poly IC-enhanced antibody production and cytotoxic T cell responses. J Immunol 2008;180:683-7
   PubMed Web of Science ®Google Scholar
• McCartney S, Vermi W, Gilfillan S, Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells. J Exp Med 2009;206:2967-76
   PubMed Web of Science ®Google Scholar
• Miyake T, Kumagai Y, Kato H, Poly I:C-induced activation of NK cells by CD8 alpha+ dendritic cells via the IPS-1 and TRIF-dependent pathways. J Immunol 2009;183:2522-8
   PubMed Web of Science ®Google Scholar
• Wu CY, Yang HY, Monie A, Intraperitoneal administration of poly(I:C) with polyethylenimine leads to significant antitumor immunity against murine ovarian tumors. Cancer Immunol Immunother 2011;60:1085-96
   Google Scholar
• Caskey M, Lefebvre F, Filali-Mouhim A, Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans. J Exp Med 2011;208:2357-66
   PubMed Web of Science ®Google Scholar
• Kato H, Takeuchi O, Mikamo-Satoh E, Length-dependent recognition of doublestranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiationassociated gene 5. J Exp Med 2008;205:1601-10
   PubMed Web of Science ®Google Scholar
• Okada H, Kalinski P, Ueda R, Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma. J Clin Oncol 2011;29:330-6
   PubMed Web of Science ®Google Scholar
• Honda K, Taniguchi T. Toll-like receptor signaling and IRF transcription factors. IUBMB Life 2006;58:290-5
   PubMed Web of Science ®Google Scholar
• Iwakiri D, Zhou L, Samanta M, Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3. J Exp Med 2009;206:2091-9
   PubMed Web of Science ®Google Scholar
• Samanta M, Takada K. Modulation of innate immunity system by Epstein-Barr virus-encoded non-coding RNA and oncogenesis. Cancer Sci 2010;101:29-35
   PubMed Web of Science ®Google Scholar
• Bortoluci KR, Medzhitov R. Control of infection by pyroptosis and autophagy: role of TLR and NLR. Cell Mol Life Sci 2010;67:1643-51
   Google Scholar
• Lauterbach H, Bathke B, Gilles S, Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly IC. J Exp Med 2010;207:2703-17
   PubMed Web of Science ®Google Scholar
• Thomas E, Gonzalez VD, Li Q, HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons. Gastroenterology 2012;142:978-88
   PubMed Web of Science ®Google Scholar
• Kariko K, Ni H, Capodici J, Lamphier M. Weissman D. mRNA is an endogenous ligand for toll-like receptor 3. J Biol Chem 2004;279:12542-50
   PubMed Web of Science ®Google Scholar
• Swaminathan G, Rossi F, Sierra LJ, A Role for microRNA-155 modulation in the anti-HIV-1 effects of toll-like receptor 3 stimulation in macrophages. PLoS Pathog 2012;8:e1002937
   Web of Science ®Google Scholar
• Proost P, Verpoest S, Van de Borne K, Synergistic induction of CXCL9 and CXCL11 by toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids. J Leukoc Biol 2004;75:777-84
   Google Scholar
• Vandenabeele P, Declercq W, Van Herreweghe F, Vanden Berghe T. The role of the kinases RIP1 and RIP3 in TNF-induced necrosis. Sci Signal 2010;3:re4
   PubMedGoogle Scholar
• Hitomi J, Christofferson DE, Ng A, Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 2008;135:1311-23
   PubMed Web of Science ®Google Scholar
• He S, Wang L, Miao L, Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 2009;137:1100-11
   PubMed Web of Science ®Google Scholar
• Seya T, Shime H, Takaki H, TLR3/TICAM-1 signaling in RIP3 tumor necroptosis. Oncoimmunology 2012;1:917-23
   PubMed Web of Science ®Google Scholar
• Eksioglu EA, Zhu H, Bayouth L, Characterization of HCV interactions with Toll-like receptors and RIG-I in liver cells. PLoS One 2011;6:e21186
   Web of Science ®Google Scholar
• Heil F, Hemmi H, Hochrein H, Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004;303:1526-9
   PubMed Web of Science ®Google Scholar
• Ebihara T, Shingai M, Matsumoto M, Hepatitis C virus-infected hepatocytes extrinsically modulate dendritic cell maturation to activate T cells and natural killer cells. Hepatology 2008;48:48-58
   PubMed Web of Science ®Google Scholar
• Lion E, Anguille S, Berneman ZN, Poly(I:C) enhances the susceptibility of leukemic cells to NK cell cytotoxicity and phagocytosis by DC. PLoS ONE 2011;6:e20952
   PubMed Web of Science ®Google Scholar
• Ebihara T, Masuda H, Akazawa T, Induction of NKG2D ligands on human dendritic cells by TLR ligand stimulation and RNA virus infection. Int Immunol 2007;19:1145-55
   PubMed Web of Science ®Google Scholar
• Zhou Z, Zhang C, Zhang J, Tian Z. Macrophages help NK cells to attack tumor cells by stimulatory NKG2D ligand but protect themselves from NK killing by inhibitory ligand Qa-1. PLoS ONE 2012;7:e36928
   Web of Science ®Google Scholar
• Ngoi SM, St Rose MC, Menoret AM, Presensitizing with a toll-like receptor 3 ligand impairs CD8 T-cell effector differentiation and IL-33 responsiveness. Proc Natl Acad Sci USA 2012;109:10486-91
   PubMed Web of Science ®Google Scholar
• Ashkenazi A, Dixit VM. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 1999;11:255-60
   PubMed Web of Science ®Google Scholar
• Andersson A, Yang SC, Huang M, IL-7 promotes CXCR3 ligand-dependent T cell antitumor reactivity in lung cancer. J Immunol 2009;182:6951-8
   PubMed Web of Science ®Google Scholar
• Sawa Y, Arima Y, Ogura H, Hepatic interleukin-7 expression regulates T cell responses. Immunity 2009;30:447-57
   PubMed Web of Science ®Google Scholar
• Starkhammar M, Kumlien Georen S, Swedin L, Intranasal administration of poly(I:C) and LPS in BALB/c mice induces airway hyperresponsiveness and inflammation via different pathways. PLoS One 2012;7:e32110
   Web of Science ®Google Scholar
• Nagpal ML, Davis J, Lin T. Overexpression of CXCL10 in human prostate LNCaP cells activates its receptor (CXCR3) expression and inhibits cell proliferation. Biochim Biophys Acta 2006;1762:811-18
   PubMed Web of Science ®Google Scholar
• Kalinski P, Mailliard RB, Giermasz A, Natural killer-dendritic cell cross-talk in cancer immunotherapy. Expert Opin Biol Ther 2005;5:1303-15
   PubMed Web of Science ®Google Scholar
• Longhi MP, Trumpfheller C, Idoyaga J, Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. J Exp Med 2009;206:1589-602
   PubMed Web of Science ®Google Scholar
• Purwar R, Schlapbach C, Xiao S, Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells. Nat Med 2012;18:1248-53
   PubMed Web of Science ®Google Scholar
• Fujii S, Liu K, Smith C, The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J Exp Med 2004;199:1607-18
   PubMed Web of Science ®Google Scholar
• Servet C, Zitvogel L, Hosmalin A. Dendritic cells in innate immune responses against HIV. Curr Mol Med 2002;2:739-56
   PubMedGoogle Scholar